Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
The Older Adult Hematologic Malignancy (OHM) Program is a specialized Dana-Farber/Brigham and Women's Cancer Center (DF/BWCC) research and clinical service that addresses the specialized needs of blood cancer patients who are age 70 and older.
Our program is focused not only on identifying the best treatments for older patients with hematologic malignancies, but also on managing any other health and wellness issues they face. In the OHM Program, each patient receives collaborative care from
both their DF/BWCC oncologist and a geriatrician from the Brigham and Women's Hospital Division of Aging. Importantly, visits with both providers occur on-site at Dana-Farber.
The Older Adult Hematologic Malignancy (OHM) Program offers older patients the best cancer care available, while also taking into account other illnesses or concerns specific to this growing population. This includes baseline assessment of frailty for
all new patients 70 or older — a unique component of our program — and for those who are determined to need it, comprehensive geriatric assessment and management, including:
Our geriatricians also address any concerns or questions about:
Based on this comprehensive geriatric assessment, our team works closely with Dana-Farber/Brigham and Women's Cancer Center oncologists to create an individualized treatment plan. In addition, our patients are invited to participate in research protocols
tailored to older adults, including clinical trials and tissue banking efforts. We are grateful for the support of the Mary P. Murphy Fund for Hematologic Malignancies for help in sustaining this program.
Tammy Hsieh, MDDr. Hsieh describes her role as a geriatrician in our Older Adult Hematologic Malignancy Program. Dr. Hshieh co-manages a patient’s care with Dana-Farber’s oncologists, and helps identify and manage an older patient’s medical, cognitive, or social issues while the patient goes through cancer treatment.
New Patient Appointments
Clinical Trials Questions?
Read about one patient's experience with the Older Adult Hematologic Malignancies Program.
As a new Dana-Farber patient, find answers to questions about your first visit: what to bring, how to find us, where to park, and how to prepare.
We offer a wide range of services, from financial planning to creative arts to spiritual counsel, to support our patients through their cancer experiences.